Parry-Romberg Syndrome Market 2019 size, share, Analysis, Growth, Guidelines, Overview, Upcoming Trends and Forecast to 2023
According to the National Organization for Rare Disorder,
Parry-Romberg syndrome is a rare and acquired disorder, which slowly shrink the
skin and tissues of half of the face in most of the cases. In rare cases, both
sides of the face are affected. In some cases, it may also affect the limbs
usually on the same side of the body.
The global
Parry-Romberg syndrome market is expected grow at a steady CAGR of 7.8%
during the forecasted period.
The global Parry-Romberg syndrome market is majorly driven
by the increasing skin diseases patient population, increasing prevalence
neurological disorders, and rapidly increasing demand for better diagnosis
& treatment methods.
Key players of the market:
·
DePuy Synthes (U.S.)
·
Johnson & Johnson Services, Inc. (US)
·
Medtronic (Ireland,
·
Abbott (US)
·
Immediate Media Company Ltd. (US)
·
Taj Pharmaceuticals Ltd.
·
Pfizer, Inc.
·
Sanofi-Aventis
·
Biogen,Inc
·
GlaxoSmithKline, Inc.
·
AstraZeneca plc.
Request Free Sample Report at:
Segmentation
The global Parry-Romberg syndrome market is segmented
- on the basis of diagnosis, treatment, and end users.
- On the basis of diagnosis, the market is segmented into physical examination, MRI, serum test, and other.On the basis of treatment, the market is categorized into drug treatment, surgery, and others. Drug treatment is further segmented into methotrexate, corticosteroids, cyclophosphamide, and azathioprine, and other. Surgery segment is sub-segmented into orthognathic surgery, microsurgical reconstructive surgery, and others.
- On the basis of end user, the market is segmented into hospitals & clinics, physical therapists, and others.
Intended Audience
- Pharmaceutical Companies
- Medical Devices Manufacturer
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Access Report Details @ https://www.marketresearchfuture.com/reports/parry-romberg-syndrome-market-4395
Regional Analysis
America accounts for the largest Parry-Romberg syndrome
market owing to constantly increasing patient population of skin diseases, eye
diseases, neurological disorder, and increasing government support for
research.
Europe holds the second position in the market due to
increasing development and more focus on healthcare domain. Countries such as Germany
and France are investing more in research & development to develop new
treatment methods for various skin diseases and eye disorder.
Asia Pacific is expected to be the fastest growing region
for Parry-Romberg syndrome market. Increasing geriatric population, rising
healthcare expenditure, and increasing prevalence of skin diseases drives the
growth of the market. Moreover,
developing countries such as India are focusing more on research &
development by investing more in healthcare, which will boost the market
growth.
About Us:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Comments
Post a Comment